116 Grants (Page 3 of 5)
2008
Optimization of drug-like compounds for treatment of spinal muscular atrophy
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (ID: 1R21HD057402-01), $225,000USD, 02/01/2008 -- 01/31/2010
 
Small Molecule Inhibitors of Oncogenic Human Papillomavirus
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA119904-01A2), $354,628USD, 01/15/2008 -- 12/31/2011
2007
Control of Papillomavirus Expression and Transformation
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2R01CA058376-14A1), $360,126USD, 09/24/1993 -- 05/31/2012
 
Functions of Human Papillomavirus E6
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA107394-04), $310,653USD, 04/08/2004 -- 02/28/2009
 
High Throughput Screen for Compounds to Treat Papillomavirus Induced Cancers
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R21CA121927-02), $119,919USD, 04/22/2006 -- 09/30/2008
2006
Control of Papillomavirus Expression and Transformation
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA058376-13), $345,461USD, 09/24/1993 -- 12/31/2006
 
Functions of Human Papillomavirus E6
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA107394-03), $286,461USD, 04/08/2004 -- 02/28/2009
 
High Throughput Screen for Compounds to Treat Papillomavirus Induced Cancers
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R21CA121927-01), $123,405USD, 04/22/2006 -- 03/31/2008
2005
Control of Papillomavirus Expression and Transformation
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA058376-12), $353,775USD, 09/24/1993 -- 12/31/2006
 
Functions of Human Papillomavirus E6
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA107394-02), $293,355USD, 04/08/2004 -- 03/31/2009
 
Papillomavirus Inhibitors for AIDS-related Malignancies
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA097922-04), $279,388USD, 07/29/2002 -- 06/30/2006
2004
Control of Papillomavirus Expression and Transformation
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA058376-11), $393,776USD, 09/24/1993 -- 12/31/2006
 
Functions of Human Papillomavirus E6
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA107394-01), $293,355USD, 04/08/2004 -- 03/31/2009
 
MOLECULAR PATHOGENESIS OF SPINAL MUSCULAR ATROPHY
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5R01NS040275-06), $318,000USD, 07/01/2000 -- 06/30/2006
 
MOLECULAR PATHOGENESIS OF SPINAL MUSCULAR ATROPHY
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 3R01NS040275-06S1), $32,400USD, 07/01/2000 -- 06/30/2005
 
Papillomavirus Inhibitors for AIDS-related Malignancies
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA097922-03), $279,388USD, 07/29/2002 -- 06/30/2006
2003
Control of Papillomavirus Expression and Transformation
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA058376-10), $353,775USD, 09/24/1993 -- 12/31/2006
 
MOLECULAR PATHOGENESIS OF SPINAL MUSCULAR ATROPHY
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5R01NS040275-05), $318,000USD, 07/01/2000 -- 06/30/2005
 
Papillomavirus Inhibitors for AIDS-related Malignancies
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA097922-02), $279,388USD, 07/29/2002 -- 06/30/2006
2002
Control of Papillomavirus Expression and Transformation
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2R01CA058376-09A1), $351,551USD, 09/24/1993 -- 12/31/2006
 
MOLECULAR PATHOGENESIS OF SPINAL MUSCULAR ATROPHY
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5R01NS040275-04), $318,000USD, 07/01/2000 -- 06/30/2005
 
Papillomavirus Inhibitors for AIDS-related Malignancies
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA097922-01), $279,388USD, 07/29/2002 -- 06/30/2006
2001
CORE--AIDS RELATED MALIGNANCY
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 3P30AI042853-04S1-9003), $129,540USD, 09/01/2001 -- 08/31/2002
 
CORE--AIDS RELATED MALIGNANCY
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5P30AI042853-04-9003), 09/01/2001 -- 08/31/2002
 
FUNCTIONS OF THE HUMAN PAPILLOMAVIRUS E6 ONCOPROTEIN
ANDROPHY, ELLIOT J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA073558-05), $138,655USD, 01/01/1997 -- 09/30/2001